Clinical Research Services
1,000+ Infusions Administered
Purpose-Built for Psychedelic Research.
Sanctuary Healthcare operates as a full service clinical research organization with a medical specialty in psychedelic-assisted therapies. Our licensed clinic in Boca Raton serves as an active trial site for Phase I-IV studies, with existing infrastructure, board-certified physicians, and a pre-qualified patient population.
Partner with our research team:
Accepting sponsor inquiries for ketamine, psilocybin, and MDMA-assisted therapy trials.
7000 W Palmetto Park Rd.
Suite 406, Boca Raton, FL 33433.
Why Sanctuary as Your Trial Site
- Active Clinical Infrastructure: Licensed infusion suite with monitoring equipment, crash cart protocols, and dedicated treatment rooms already operational.
- Experienced Clinical Team: Board-certified anesthesiologists and psychiatrists with hundreds of supervised ketamine sessions.
- Specialized Patient Population: Pre-qualified registry across treatment-resistant depression, PTSD, and anxiety disorders ready for enrollment screening.
- Advancing the Field: Our research team is actively contributing to the evidence base for psychedelic medicine and regulatory approval pathways.
Controlled Setting, Rigorous Protocol.






As psychedelic medicine moves rapidly through the FDA approval pipeline, sponsors need clinical trial sites with real operational experience, not just regulatory paperwork. Sanctuary Healthcare is a licensed clinical research site in Boca Raton, Florida specializing in psychedelic-assisted therapy trials, including ketamine, psilocybin, and MDMA-assisted treatment protocols.
Our facility serves as an active trial site for Phase I through Phase IV studies targeting treatment-resistant depression, PTSD, anxiety disorders, and substance use disorders. Unlike general-purpose CRO networks, we bring hands-on clinical experience from hundreds of supervised ketamine infusions, a pre-qualified patient population, and a purpose-built infusion environment designed specifically for psychedelic medicine research.
Sponsors working with Sanctuary benefit from a site that understands the unique challenges of psychedelic clinical trials, including blinding methodology, set and setting protocols, integration therapy requirements, and Schedule II/III controlled substance handling. We work with biotech sponsors, academic institutions, and pharmaceutical companies to accelerate enrollment and maintain the highest standards of GCP compliance throughout the trial lifecycle.
If you are seeking a qualified psychedelic clinical trial site in South Florida, contact our research team to request a feasibility assessment.